Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study. [electronic resource]
- European journal of preventive cardiology Aug 2013
- 678-85 p. digital
Aged Benzaldehydes--therapeutic use Biomarkers--blood Blood Glucose--analysis Blood Pressure Cardiovascular Agents--therapeutic use Coronary Disease--blood Double-Blind Method Female Guideline Adherence Humans Hypolipidemic Agents--therapeutic use Lipids--blood Male Middle Aged Oximes--therapeutic use Phospholipase A2 Inhibitors--therapeutic use Practice Guidelines as Topic Practice Patterns, Physicians' Prevalence Prospective Studies Risk Factors Secondary Prevention--methods Time Factors Treatment Outcome